Dr. Mingqian Tan is a chemist who is currently working in Dalian Institute of Chemical Physics (DICP), Chinese Academy of Sciences(CAS). He has 14 years experience in working with in vivo and in vitro tumor imaging and bioassay to understand the underlying mechanisms of tumor targeting and imaging guided tumor therapy. His research interest includes development of novel nanoparticles with greater therapeutic potential and fewer side effects in the treatment of tumor. In 2005, he received his Ph.D. degree in analytical chemistry from DCP, CAS. He then went to the University of Victoria, Canada and worked there as a post-doctor in 2006. From Nov. 2007 to Dec. 2010, he worked as a Senior Research Associate in the University of Utah and Case Western Reserve University, respectively, in the United States. From Jan 2011 to present, he worked as Associate Professor in DICP, CAS. He has published more than 30 peer-reviewed papers, 22 patents, one scientific book entitled with “Nanomaterials for tumor targeting theranostics” as well as three book chapters. He received the award for Hundred Talents Program of DICP and President Award of Chinese Academy of Sciences in 2010 and 2005, respectively. He is now a leading researcher of the National Nature Science Foundation of China (No. 91227126), National Instrumentation Program (No. 2013YQ17046307) and the Nature Science Foundation of Liaoning Province, China (No. 2013020177). He is also the scholarship winner of the 1st International Congress on MRI & the 18th Annual Scientific Meeting of Korean Society of magnetic resonance in medicine in 2013.
Abstracts this author is presenting: